您的位置: 首页 > 农业专利 > 详情页

ANTICORPS ANTI-HER2 BISPÉCIFIQUE
专利权人:
Beijing Mabworks Biotech Co. Ltd.
发明人:
LI, Feng,ZHANG, Boyan,YE, Pei,ZHAO, Jian,HUANG, Sijia,JIN, Chunyang
申请号:
EP17830498
公开号:
EP3487888A4
申请日:
2017.07.21
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention relates to humanized bispecific anti-HER2 antibodies that comprise one antigen binding site containing variable regions of heavy and light chain of trastuzumab, and another antigen binding site containing variable regions of heavy and light chain of pertuzumab. The bispecific anti-HER2 antibodies is effective for treating cancer, such as breast cancer, gastric cancer, or ovarian cancer. Preferred bispecific anti-HER antibodies of the present invention are afucosylated antibodies.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充